Abiopharma

Amneal Pharmaceuticals, Inc. - Amneal Unveils Bold New Brand to Reimagine What’s Possible in Making Medicine Accessible for All

New Form S-8 POS - iRhythm Holdings, Inc. Filed: 2026-01-12 AccNo: 0001104659-26-002904 Size: 86 KB

(30% Negative) Apellis Pharmaceuticals Inc (APLS) Announces Delay in initiated Trials for EMPAVELI in two additional nephrology indications Due to Regulatory Process, Safety Review

Gandhi Balaji 🔴 sold 8.0K shares of Phreesia, Inc. (PHR) at $17.01 Transaction Date: Jan 08, 2026 | Filing ID: 000012

New Form 424B5 - Foghorn Therapeutics Inc. Filed: 2026-01-12 AccNo: 0001193125-26-010520 Size: 391 KB

Final approval of NDA #NDA #211241 for COPPER HISTIDINATE. Decision date: 01/12/2026

Summit Plc - Statement of changes in beneficial ownership of securities

(10% Negative) SAB Biotherapeutics (SABSW) Announces Delay in investors Trials for relation to holding Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

New Form 424B5 - Cingulate Inc. Filed: 2026-01-12 AccNo: 0001493152-26-001871 Size: 17 KB

(99% Neutral) MaxCyte Inc (MXCT) Reports Q1 2026 Financial Results

(90% Positive) Olema Oncology (OLMA) Announces Enrollment Update for opportunity Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(70% Positive) Biomarin Pharmaceutical Inc (BMRN) Reports Q1 2026 Financial Results

(99% Neutral) Assertio Holdings Inc. (ASRT) Announces Update on Collaboration with Common Stock

(80% Positive) Delcath Systems Inc (DCTH) Announces Clinical Development Update

(99% Neutral) Know Labs (KNW) Announces Executive Departure